Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced on September 30, 2025 that it has filed an amendment to its Certificate of Incorporation with the Delaware Secretary of State and amended its bylaws to change the company’s name to Solana Company. The ticker symbol for its Class A common stock will remain HSDT. The filing marks the first formal step in rebranding the company to reflect its new strategic focus.
In addition to the name change, HSDT entered into a non‑binding letter of intent with the Solana Foundation. The agreement commits the company to conduct all on‑chain activity exclusively on the Solana blockchain, to pursue institutional partnership referrals, and to co‑host events, roundtables, and other joint initiatives that highlight Solana’s capabilities. The letter also gives HSDT the option, subject to certain conditions, to purchase a specified amount of SOL tokens from the Foundation at a discount.
The announcement signals a significant shift toward a digital‑asset treasury strategy. HSDT still holds cash from a recent $500 million PIPE financing, which the company intends to deploy to accumulate SOL tokens and generate on‑chain yield. By aligning its corporate identity with the Solana ecosystem, HSDT is positioning itself to tap new revenue streams and potentially enhance shareholder value through blockchain‑based financial activities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.